More about
Mmr-Deficient Tumors
News
September 16, 2024
1 min read
Save
Benefit of adjuvant pembrolizumab in endometrial cancer varies by mismatch repair status
The addition of pembrolizumab to adjuvant chemotherapy improved DFS for certain women with newly diagnosed high-risk endometrial cancer, according to randomized phase 3 study results presented at ESMO Congress.